Evidence map›Paper›PMID 37089569›Full record

ReviewFrontiers in microbiology2023

Antimicrobial susceptibility surveillance and antimicrobial resistance in

Francis Kakooza, Reuben Kiggundu, Gerald Mboowa, Patrick David Kateete, Olga Tendo Nsangi, Jupiter Marina Kabahita, Bernard Ssentalo Bagaya, Daniel Golparian, Magnus Unemo

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Distribution and Factors Associated withInfectious disease reports · 2025
    Article
  5. Microorganisms · 2025
    Article
  6. Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trends.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  7. Antimicrobial susceptibility inJAC-antimicrobial resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Francis KakoozaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Reuben KiggunduUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, Uganda.
Gerald MboowaInfectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Patrick David KateeteDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Olga Tendo NsangiDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Jupiter Marina KabahitaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Bernard Ssentalo BagayaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Daniel GolparianWHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Örebro University, Örebro, Sweden.
Magnus UnemoWHO Collaborating Centre for Gonorrhoea and Other STIs, Department of Laboratory Medicine, Microbiology, Örebro University, Örebro, Sweden.
Makerere University · UGÖrebro University · SEInfectious Diseases Institute · UG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) in

Indexed as

Africaantimicrobial resistanceantimicrobial susceptibility surveillanceazithromycinceftriaxoneNeisseria gonorrhoeaeWHO enhanced GASP (EGASP)WHO Gonococcal Antimicrobial Surveillance Program (GASP)

Identifiers

PMID37089569
PMCPMC10117771
OpenAlexW4362672914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.